These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18616708)

  • 1. Effects of aromatase inhibition in hypogonadal older men: a randomized, double-blind, placebo-controlled trial.
    Burnett-Bowie SA; Roupenian KC; Dere ME; Lee H; Leder BZ
    Clin Endocrinol (Oxf); 2009 Jan; 70(1):116-23. PubMed ID: 18616708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels.
    Leder BZ; Rohrer JL; Rubin SD; Gallo J; Longcope C
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1174-80. PubMed ID: 15001605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic and psychological effects of low-dose aromatase inhibition in men with obesity-related hypogonadotropic hypotestosteronemia.
    Loves S; de Jong J; van Sorge A; Telting D; Tack CJ; Hermus A; Westerterp K; de Boer H
    Eur J Endocrinol; 2013 Nov; 169(5):705-14. PubMed ID: 23949882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men.
    Leder BZ; Finkelstein JS
    Osteoporos Int; 2005 Dec; 16(12):1487-94. PubMed ID: 15856361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels.
    Burnett-Bowie SA; McKay EA; Lee H; Leder BZ
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4785-92. PubMed ID: 19820017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of aromatase inhibition on lipids and inflammatory markers of cardiovascular disease in elderly men with low testosterone levels.
    Dougherty RH; Rohrer JL; Hayden D; Rubin SD; Leder BZ
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):228-35. PubMed ID: 15670201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of aromatization in testosterone supplementation: effects on cognition in older men.
    Cherrier MM; Matsumoto AM; Amory JK; Ahmed S; Bremner W; Peskind ER; Raskind MA; Johnson M; Craft S
    Neurology; 2005 Jan; 64(2):290-6. PubMed ID: 15668427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letrozole once a week normalizes serum testosterone in obesity-related male hypogonadism.
    Loves S; Ruinemans-Koerts J; de Boer H
    Eur J Endocrinol; 2008 May; 158(5):741-7. PubMed ID: 18426834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of aromatase inhibition vs. testosterone in older men with low testosterone: randomized-controlled trial.
    Dias JP; Melvin D; Simonsick EM; Carlson O; Shardell MD; Ferrucci L; Chia CW; Basaria S; Egan JM
    Andrology; 2016 Jan; 4(1):33-40. PubMed ID: 26588809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coadministration of anastrozole sustains therapeutic testosterone levels in hypogonadal men undergoing testosterone pellet insertion.
    Mechlin CW; Frankel J; McCullough A
    J Sex Med; 2014 Jan; 11(1):254-61. PubMed ID: 24119010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with 12 months open-label follow-up.
    Behre HM; Tammela TL; Arver S; Tolrá JR; Bonifacio V; Lamche M; Kelly J; Hiemeyer F; ; Giltay EJ; Gooren LJ
    Aging Male; 2012 Dec; 15(4):198-207. PubMed ID: 22834649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of anastrozole and testosterone versus placebo and testosterone for treatment of sexual dysfunction in men with epilepsy and hypogonadism.
    Herzog AG; Farina EL; Drislane FW; Schomer DL; Smithson SD; Fowler KM; Dworetzky BA; Bromfield EB
    Epilepsy Behav; 2010 Feb; 17(2):264-71. PubMed ID: 20096638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of the aromatase inhibitor anastrozole on bone metabolism and cardiovascular risk indices in ovariectomized, androgen-treated female-to-male transsexuals.
    Bunck MC; Toorians AW; Lips P; Gooren LJ
    Eur J Endocrinol; 2006 Apr; 154(4):569-75. PubMed ID: 16556720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
    Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
    JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone with dutasteride, but not anastrazole, improves insulin sensitivity in young obese men: a randomized controlled trial.
    Juang PS; Peng S; Allehmazedeh K; Shah A; Coviello AD; Herbst KL
    J Sex Med; 2014 Feb; 11(2):563-73. PubMed ID: 24344872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone aromatization and cognition in women: a randomized, placebo-controlled trial.
    Shah S; Bell RJ; Savage G; Goldstat R; Papalia MA; Kulkarni J; Donath S; Davis SR
    Menopause; 2006; 13(4):600-8. PubMed ID: 16837882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letrozole normalizes serum testosterone in severely obese men with hypogonadotropic hypogonadism.
    de Boer H; Verschoor L; Ruinemans-Koerts J; Jansen M
    Diabetes Obes Metab; 2005 May; 7(3):211-5. PubMed ID: 15811136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial.
    Emmelot-Vonk MH; Verhaar HJ; Nakhai Pour HR; Aleman A; Lock TM; Bosch JL; Grobbee DE; van der Schouw YT
    JAMA; 2008 Jan; 299(1):39-52. PubMed ID: 18167405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T.
    Page ST; Amory JK; Bowman FD; Anawalt BD; Matsumoto AM; Bremner WJ; Tenover JL
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1502-10. PubMed ID: 15572415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels.
    Kenny AM; Prestwood KM; Gruman CA; Marcello KM; Raisz LG
    J Gerontol A Biol Sci Med Sci; 2001 May; 56(5):M266-72. PubMed ID: 11320105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.